No Data
No Data
Botanix Pharmaceuticals Seeks AU$40 Million via Institutional Placement; Shares Rise 10%
3 Reasons to Buy This Surging ASX All Ords Healthcare Share Today
Botanix Pharmaceuticals Posts Wider Fiscal H1 Loss, Lower Revenue
Botanix Pharmaceuticals Ltd: Appendix 4D and Half Year Report
Botanix Pharmaceuticals' Prescription Gel Commercial Launch Could Drive Stock Re-rating, Euroz Hartleys Says
5 ASX All Ords Shares Starting the New Year at 52-week Highs
151820638 : In six months, it will be clear how cheap the current price of BOT stocks is, haha.
151820638 : When you delve deeper into this company, you will find that it has good products, a great team, a strong financial situation, and a vast market. The performance after half a year of commercialization will definitely bring you unexpected surprises!!!